Clinical Trial

TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients

Study acronym: WIN-HYPO2021
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To offer the possibility of a treatment that could achieve a meaningful reduction in the incidence of post-radiation therapy hypothyroidism. Thyroid dysfunction may develop from a few months to several years after patients have completed their radiation treatment. In children with chronic diseases, or given lengthy anti-neoplastic treatments, recurrent or persistent endocrine disorders may have a negative effect on growth and development into adulthood.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-04-06.
Trial Details
NCT Number NCT05316922
Lead Sponsor Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Conditions Hypothyroidism; Irradiation
Enrollment 68 participants
Start Date 2021-12-13
Primary Completion 2029-09-30 (estimated)
Study Completion 2029-09-30 (estimated)
Updated on ClinicalTrials.gov 2023-12-06